Ernexa Therapeutics Statistics
NASDAQ: ERNAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.52+0.13 (+5.44%)
Market open · Delayed 15 min · as of Oct 8, 1:24 PM ET
Ernexa Therapeutics by the numbers
Ernexa Therapeutics has a market capitalization of $4.1 million based on 1.63M shares outstanding. With trailing EPS of $-13.63, Ernexa Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 36.7% below its 50-day average and 74.4% below its 200-day average.
Average daily trading volume is 472.01K shares, or about $1.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ERNA valuation vs. peer median
| Metric | ERNA | Peer median | Difference |
|---|---|---|---|
| Market cap | $4.11M | $3.68M | +12% |
| Avg. volume | 472.01K | 276.42K | +71% |
Peer median across 8 companies: GRI, EOCN, PCSA, ONCO, JUNS, HCWB, SXTP, CMND.
Valuation
- Market cap
- $4.11M
- EPS (TTM)
- $-13.63
- Shares outstanding
- 1.63M
Price and trading
- Previous close
- 2.39
- Open
- 2.39
- Day range
- 2.14 – 2.70
- 52-week range
- 2.14 – 71.50
- Beta
- —
- Volume
- 170.84K
- Average volume
- 472.01K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 6, 2026
Additional statistics
- Market Cap
- 4.11M
- Forward Pe
- -0.26
- Eps
- -13.63
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 71.50
- Week52 Low
- 2.14
- Avg Volume
- 472.01K
- Shares Outstanding
- 1.63M
- Ma50
- 3.98
- Ma200
- 9.83
- Earnings Date
- Nov 6, 2026
- Pct From52w High
- -96.48%
- Pct From52w Low
- 18.03%